Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Peptide, derivative of AT I, cleavage product o...
Antimicrobial peptide found in amphibians.
Diterpene found in brewed, unfiltered coffee; F...
BH3 mimetic; Bcl-2 and Bcl-xl inhibitor.
ALK and IGF-1R inhibitor.
Minor kavalactone originally found in Piper met...
Polyphenol found in olive oil, antioxidant.
Endogenous cardiomodulatory peptide; NPR-A agon...
Ansamycin; bacterial DNA-dependent RNA polymera...
Peptide, involved in synapse formation and cell...
Endogenous cardiomodulatory peptide; NPR-B agon...
Aromatase inhibitor.
Peptide antigen fragment
AR antagonist.
Aminoglycoside; protein translation inhibitor.<...
Viral neuraminidase inhibitor, potential MAO-A ...
Phase II enzyme inducer; Nrf2 activator; antiox...
SIRT2 inhibitor.
Endogenous quaternary ammonium, required for fa...
G-quadruplex ligand; DNA breakage inducer.